America had more ER capacity than I think any other country on the planet. Perhaps due to a lack of preventative medicine? I don't know, but it shouldn't be due to lack of ER capacity that this is happening.
ICU capacity per capita is larger in Germany and Austria at least.
Source: https://www.oecd.org/coronavirus/en/data-insights/intensive-...
[1] https://onlinelibrary.wiley.com/doi/pdf/10.1111/j.1553-2712....
>but no investment in increasing hospital capacity
Agree, where did all the billions go? The most expensive healthcare on the planet and we can't find the money to scale and expand a year and a half later.
That being said, hospitals have not been overwhelmed in the United States. The emergency hospitals we did build mainly went unused.
Health insurers know their time in the crosshairs is coming which is why they're buying up pharmacy groups and providers, to give their offerings a sheen of actual care.
Politicians get to use them as scapegoats, and there is no way voters in the US accept taxpayer funded healthcare. Someone has to be the bad guy and allocate the limited amount of healthcare resources available, and I see no reason why the existing relationship of government makes the rules allocating the care, but MCO implements them and takes the heat would change.
Traders also seem to think the same given the gains in MCO market caps. Also, all the MCOs have profit margins of 5% or less, so this game of punting responsibility costs relatively little in the grand scheme of things.
At the root of it all is a demand for healthcare that far outstrips supply, and so these obfuscations are useful in making sure certain socioeconomic classes are able to attain a greater share of it than others.
Doubling healthcare capacity roughly lasts for about 3 extra days if no other measure is in place.
I'm all for improving healthcare, in the US or otherwise, but you just can't fire up and destroy healthcare resources like it's your k8s cluster.
Which trials demonstrated this?
...
"Among 42,094 evaluable ≥12-year-olds without evidence of prior SARS-CoV-2 infection, 77 COVID-19 cases with onset ≥7 days post-dose 2 were observed through the data cut-off (March 13, 2021) among vaccine recipients and 850 among placebo recipients, corresponding to 91.3% VE (95% CI [89.0-93.2]; Table 2). Among 44,486 evaluable participants, irrespective of prior SARS-CoV-2 infection, 81 COVID-19 cases were observed among vaccine and 873 among placebo recipients, corresponding to 91.1% VE (95% CI [88.8-93.0]).
In the all-available population with evidence of prior SARS-CoV-2 infection based on positive baseline N-binding antibody test, 2 COVID-19 cases were observed post-dose 1 among vaccine and 7 among placebo recipients. In participants with evidence of SARS-CoV-2 infection by positive nucleic acid amplification test at baseline, no difference in COVID-19 cases was observed between vaccine (n=10) and placebo (n=9) recipients (Table S5). COVID-19 was less frequent among placebo recipients with positive N-binding antibodies at study entry (7/542; ~1.3% attack rate) than among those without evidence of infection at study entry (1015/21,521; ~4.7% attack rate), indicating ~72.6% protection by previous infection."
...
Efficacy peaked at 96.2% during the interval from 7 days to <2 months post-dose 2, and declined gradually to 83.7% from 4 months post-dose 2 to the data cut-off, an average decline of ~6% every 2 months. Ongoing follow-up is needed to understand persistence of the vaccine effect over time, the need for booster dosing, and timing of such a dose. Most participants who initially received placebo have now been immunized with BNT162b2, ending the placebo-controlled part of the study. Nevertheless, ongoing observation of participants through up to 2 years in this study, together with real-world effectiveness data,14-17 will determine whether a booster is likely to be beneficial after a longer interval. Booster trials to evaluate safety and immunogenicity of BNT162b2 are underway to prepare for this possibility.
https://www.medrxiv.org/content/10.1101/2021.07.28.21261159v...
From [1] page 13:
> Efficacy is being assessed throughout a participant’s follow-up in the study through surveillance for potential cases of COVID-19. If, at any time, a participant develops acute respiratory illness, an illness visit occurs. Assessments for illness visits include a nasal (midturbinate) swab, which is tested at a central laboratory using a reverse transcription-polymerase chain reaction (RT-PCR) test (e.g., Cepheid; FDA authorized under EUA), or other sufficiently validated nucleic acid amplification-based test (NAAT), to detect SARS-CoV-2.
So, if you didn't present symptoms of an acute respiratory infection, you weren't PCR tested in the trial. Since we know that the vast majority of PCR positive tests come from asymptomatic and very mild cases, this trial can't be used to draw any conclusions about it's ability to prevent infection.
Here's another interesting bit from page 42:
> Among 3410 total cases of suspected but unconfirmed COVID-19 in the overall study population, 1594 occurred in the vaccine group vs. 1816 in the placebo group. Suspected COVID-19 cases that occurred within 7 days after any vaccination were 409 in the vaccine group vs. 287 in the placebo group. It is possible that the imbalance in suspected COVID-19 cases occurring in the 7 days postvaccination represents vaccine reactogenicity with symptoms that overlap with those of COVID-19. Overall though, these data do not raise a concern that protocol-specified reporting of suspected, but unconfirmed COVID-19 cases could have masked clinically significant adverse events that would not have otherwise been detected
The document doesn't outline what 'suspected' cases are.
Here is the paragraph that specific states data is limited around transmission (page 48):
> Vaccine effectiveness against transmission of SARS-CoV-2 Data are limited to assess the effect of the vaccine against transmission of SARS-CoV-2 from individuals who are infected despite vaccination. Demonstrated high efficacy against symptomatic COVID-19 may translate to overall prevention of transmission in populations with high enough vaccine uptake, though it is possible that if efficacy against asymptomatic infection were lower than efficacy against symptomatic infection, asymptomatic cases in combination with reduced mask-wearing and social distancing could result in significant continued transmission. Additional evaluations including data from clinical trials and from vaccine use post-authorization will be needed to assess the effect of the vaccine in preventing virus shedding and transmission, in particular in individuals with asymptomatic infection.
Now, this is if you take the studies at face value, which I don't. We know Pfizer and the FDA are full of frauds and grifters.
Sadly most don’t want to consider it and just parrot what they’ve been programmed to by the television. The worse part is they think they are righteous or whatever. So delusional.
Instead we see the opposite, which has little to do with the best interests of the citizens, including the funneling of tax dollars to Pfizer and the rest. The parent comment highlights that and explains what’s actually going on, despite the narrative provided by <compliant> ”experts.”
A life is in your hands. I’ve witnessed and lived through both scenarios. The majority of the time people want the pills.
I am curious how you would solve for modern human ailments. Would you impose a government sanctioned food protocol? Would you let people die who refuse to increase their quality food intake and exercise?
Yes, however it starts with improving the food preparation options and raising food quality. There is horrible stuff in our food - stuff that is outlawed in Europe because it is a known toxin.
Something has clearly gone wrong in the US and it’s a pretty patronizing position you have taken to put the blame entirely on the public. The government institutions supposed to be watching out for this stuff have failed, and are likely corrupt.
> Would you impose a government sanctioned food protocol?
Nah, not needed. This is fixed by a PR campaign and some cultural adjustments.
For example, for some reason the media has been promoting “body positivity” in recent years and encouraging unhealthy lifestyles. Those people who actually bought into that idea were set up in a worse position when this kicked off.
Probably not promoting bad ideas like that would be a good place to start. The commies will whine that it’s “fascist” or not “big hearted” whatever, though.
—-
In the end, I guess only people who can see through the lies will survive, and that’s just the game we’re playing now. That doesn’t mean that we should accept living a society where this is normal.
All the billions handed out to the vaccine companies and the propaganda machines, but no investment in increasing hospital capacity. These mega corporations that run the hospitals, they prey on people's caring capacity. Nurses haven't already left the field because nothing else pays a living wage and they have 60k in student debt to pay off.
Let's just blame the unvaccinated though. That ensures Pfizer keeps buying ads on CNN.